Back to journals
Academic JournalOpen Access

Scientific Reports

70 Papers Indexed in Blossom

Data updated

Publication Landscape

How the 70 psychedelic papers Blossom tracks from Scientific Reports line up by year, topic and compound. This is the journal's psychedelic-research output in Blossom's records as of July 2026; its full catalogue is much larger.

How much psychedelic research does Scientific Reports carry?

Sourced

Tracked papers by publication year. Click a year for the running total.

13papers published in 2023

+117% vs 2022

47 published by 2023

Browse papers→

Don't read as the journal's total output: only the 70 of 70 tracked psychedelic papers from Scientific Reports with a recorded publication date are counted, and Blossom tracks only psychedelic-relevant papers, so the full catalogue is much larger. The current year is still filling in.

What does Scientific Reports publish on?

Sourced

Tracked papers per topic. Orange marks the largest research focus.

Depressive Disorders
31
Anxiety Disorders
20
Addiction & Substance Use
17
Neuroimaging & Brain Measures
14
PTSD
8
Personality & Trait Factors
6
Interpersonal Functioning & Social Connectedness
6
Equity and Ethics
5
Other
48

Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not the journal's full catalogue.

Which compounds does Scientific Reports cover?

Sourced

Tracked papers per compound. Orange marks the most-covered compound.

Psilocybin
32
LSD
16
Ayahuasca
14
MDMA
10
DMT
7
Mescaline
5
5-MeO-DMT
3
Ketamine
3
Other
1

Don't read shares as adding to 100%: a paper studying several compounds counts once per compound, and placebo comparator arms are not shown. These are the psychedelic-relevant papers Blossom tracks.

Research Footprint

Scientific Reports has 70 tracked papers indexed in Blossom (2017–2026) from 377 authors, most often covering Psilocybin, LSD and Ayahuasca, across Depressive Disorders, Anxiety Disorders and Substance Use Disorders (SUD).

Published Papers

Open Accessindividual

Changes in trauma symptoms of discrimination after MDMA-assisted psychotherapy for posttraumatic stress disorder

This preliminary study (n=5) examined MDMA-assisted psychotherapy for post-traumatic stress disorder and found that discrimination-related trauma symptoms fell after treatment in a small, diverse group of participants. All participants reported marked improvement, but the sample was very small.

Published
Journal
Scientific Reports
Authors
Williams, M. T., Faber, S. C., Sloshower, J., Tullis-Robinson, L., Pérez Rosal, S. R.
Open Accessindividual

Major life changes following psychedelic use: A retrospective survey among people using psychedelics naturalistically

This survey (n=581) evaluates the Psychedelic-related Major Life Changes Questionnaire (P-MLCQ) in people reporting naturalistic psychedelic use. It finds that 82.96% of participants reported major life changes in at least one domain, including goals (53.7%), values (53.53%), and spirituality (49.05%), with changes rated highly positively (M = 4.64/5). Frequency of use correlated with more changes (r = 0.34), while education level was negatively associated with the number of changes (β = -0.137).

Published
Journal
Scientific Reports
Authors
Aday, J. S., Glynos, N., Baker, A., Pouyan, N., Barron, J., Herberholz, M., Kruger, D. J., Woolley, J. D., Boehnke, K. F.
Open Accessindividual

Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat

This secondary analysis of a randomised controlled trial of DMT/harmine in experienced meditators found that meditation under DMT-harmine differed from placebo in its thematic and experiential profile while still sharing some semantic features. Using NLP-based analysis of phenomenological interviews, the study also suggested overlap between meditative and psychedelic states and highlighted the strong influence of context and spiritual framing on subjective experience.

Published
Journal
Scientific Reports
Authors
Schlomberg, J. T. T., Meling, D., Grylka, R., Vasella, E. A., Augustinovic, D., Scheidegger, M.
Open Accessindividual

Pilot study of psilocybin in patients with post-treatment lyme disease

In an open‑label, single‑arm pilot study of 20 patients with post‑treatment Lyme disease, two psilocybin sessions with psychological support produced significant, sustained reductions in symptom burden (40% decrease in GSQ‑30 at six months) and improvements in both physical and mental quality of life. The intervention was feasible and well-tolerated with no serious related adverse events, supporting further controlled trials of psilocybin‑assisted therapy for PTLD.

Published
Journal
Scientific Reports
Authors
Garcia-Romeu, A., Naudé, G. P., Rebman, A. W., So, S., Yaffe, A., Geithner, I., Kozero, E. A., Yang, T., Soloski, M. J., Aucott, J. N.
Open Accessindividual

Inhaled N, N-dimethyltryptamine diminishes connectivity between the ventral tegmental area and the nucleus accumbens: relevance to pathologies of mesolimbic and mesocortical pathways

In a within-subject pharmacoimaging study of 11 healthy psychedelic-experienced volunteers, inhaled DMT acutely reduced connectivity between the left ventral tegmental area and the right nucleus accumbens while increasing connectivity between the nucleus accumbens and anterior cingulate cortex and between the medial prefrontal cortex and anterior cingulate. These connectivity shifts correlated with changes in volition and perception and suggest a potential therapeutic mechanism for disorders of reward processing.

Published
Journal
Scientific Reports
Authors
Lima, G., Soares, C., Teixeira, M., Pais, M., Cabral, C., Rijo, P., Castelo-Branco, M.
Open Accessindividual

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study

This open-label study (n=9) found that an encapsulated DMT-harmala alkaloid product (pharmahuasca) produced dose-dependent mystical experiences that exceeded those reported in most previous ayahuasca studies and were associated with beneficial persisting psychological effects in healthy volunteers.

Published
Journal
Scientific Reports
Authors
Perkins, D., Halman, A., Urokohara, A., Palumbo, J., Low, M., Ruffell, S., Galvão-Coelho, N., Collins, L., Norman, A., Sarris, J.

Quick Facts

Papers Indexed
70
h-Index
347
Open Access
Yes
Publisher
Oxford University Press
Country
United Kingdom
Website
Visit